Weight Loss and Obesity Management Market Analysis

Weight Loss and Obesity Management Market Analysis

To get key market trends

  Download Free Sample

Based on product & services, the drugs segment is further segmented into GLP-1 receptor agonists, lipase inhibitors, combination drugs, serotonin receptor agonists, and other drugs. Similarly, equipment segment is also further segmented as fitness equipment, fitness monitoring equipment, surgical equipment, and other equipment. The supplements segment held the majority of market share of about 48.3% in 2023.

• The dominating share of supplement segment can be attributed to their easy availability over the counter without requiring the prescriptions from medical practitioners. This makes them easily accessible to obese patients.

   

• Availability of weight loss supplements as herbal/natural products is gaining increasing popularity among obese patients that perceives supplements as a safer alternative to prescription drugs. While efficacy and safety vary among supplements, the perception of obese patients towards supplements and strong brand marketing by supplement manufacturers is contributing to significantly high adoption of supplements in weight loss and obesity management industry.

   

• Moreover, supplement industry is less regulated in comparison to pharmaceuticals, this allows the manufacturers to quickly introduce new products into the market with less regulatory hurdles.

Based on age group, the weight loss and obesity management market is classified into adults and children. The adult segment dominated the market with a revenue of about USD 206.4 billion in 2023.

• Leading share of adult segment can be attributed to high prevalence of obesity among adults. According to the World Health Organization in 2022, about 2.5 billion adults (18 years and older) were overweight in comparison to 427 children under 5 years and 5-19 years of age.

   

• Moreover, increasing lifestyle related disorders among adult population is also driving an increasing prevalence of obesity, thereby driving the demand for weight loss and obesity management in the segment.

North America weight loss and obesity management market accounted for 42.6% of market share in global market in 2023 and is predicted to reach USD 199.4 billion by 2032.

• Leading share of North America can be attributed to high prevalence of obesity and increasing awareness towards fitness activities. Owing to increasing burden of obesity, governments are promoting healthy lifestyle practices and nutritional awareness through campaigns and national programs such as Active People, Healthy Nation, a Center for Disease Control and Prevention- led initiative aimed at increasing the physical activity levels of 27 million Americans by 2027. Increasing awareness towards healthy lifestyle is contributing to an increasing demand for obesity treatment supplements, meals, and medications.

   

• Furthermore, presence of established healthcare infrastructure and strong nutraceutical and pharmaceutical industry is aiding to an easy availability of treatment options for obese and overweight patients. According to the U.S. FDA, by April 2024, about 11 medications were approved for weight loss treatments including both short term and long-term use.

   

The U.S. weight loss and obesity management market was valued at USD 87 billion in 2023 and is anticipated to grow at a CAGR of 8.2% through 2032.

• Increasing growth in extreme obesity in the U.S. has surged the demand for bariatric surgeries. According to the ASMBS, total number of bariatric surgeries in the U.S. has increased from 158,000 in 2011 to 279,967 in 2022. Increase in surgical interventions is driving the demand for surgical equipment, thereby contributing to a leading share of U.S. market.

   

• Furthermore, increasing adoption of nutraceutical-based treatments for weight loss in the country is also aiding to the revenue growth in the weight loss and obesity management industry. According to a 2022 article from National Institutre of Health, about 15% of the U.S. adults have utilized a weight-loss dietary supplement at some stage in their lives.

   

Germany weight loss and obesity management market is expected to show significant growth opportunities during 2024 to 2032.

• Germany is witnessing increasing growth in obesity management services due to the presence of large number of private organizations and clinics such as Földiklinik, Neo Fatbury, and YourWeightcare. These organizations and clinics are offering nutritional advice, exercise programs, psychological support, and diagnostics and treatment consultation. Increasing adoption of such obesity management services are driving the revenue growth in Germany.

   

• Furthermore, growing health expenditure on obesity treatment is also contributing to the regional revenue share. According to the Organisation for Economic Co-operation and Development, in 2019, overweight accounts for 10.7% of health expenditure in Germany.

   

India weight loss and obesity management market is anticipated to grow remarkable growth over the coming years.

• Increasing burden of obesity together with increasing availability of prescription medication is driving the revenue growth in the India weight loss and obesity management business.
  
   
• For instance, according to the Global Obesity Observatory of World Obesity Federation, in 2019, the economic impact of obesity and overweight in India was anticipated to remain at USD 28.95 billion. As a result pharmaceutical companies are increasingly focusing towards launching new prescription medication for obesity treatment in India. For instance, Novo Nordisk launched semaglutide in January 2022.

   

• Additionally, government campaign to reduce obesity such as Rashtriya Kishor Swasthya Karyakram and Eat Right India Movement are also contributing towards increased awareness for weight loss and obesity management in the country, thereby contributing to the overall market growth.